Clinical Trials Browser

Phase 3 × Prostatic Neoplasms × Metformin × Clear all

NCT03031821 2024-10-04

PRIME

Phase 3 Terminated

Prostatic Neoplasms, Metabolic Syndrome

NCT01864096 2024-01-24

MAST

Phase 3 Unknown

Neoplasms, Prostatic Neoplasms